Roundtable Discussion: Improving Consistency by Embedding Donor Selection into Early Autologous Cell Therapy Development
2:30 pm - Wednesday 2nd December 2026
- Identifying donor driven variability to reducing inconsistency in assays and final product quality
- Using donor characterisation to predicting manufacturing performance earlier in development
- Aligning cross functional decisions to minimising rework failed batches and variability in release
